During the past decade, TRANTOR 99 Bt. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TRANTOR 99 Bt." are "Diabetes Mellitus, Type 2" (1 trials), "Type 1 Diabetes Mellitus" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "TRANTOR 99 Bt." in a lesser frequency.

Most popular intervention types in "TRANTOR 99 Bt." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Insulin Degludec" (1 trials), "Insulin Lispro" (1 trials), "Tirzepatide" (1 trials) and "Ultra-Rapid Lispro" (1 trials). Other intervention names were less common.

The vast majority of trials in "TRANTOR 99 Bt." are 3 trials for "All" genders.

Currently, there are NaN active trials in "TRANTOR 99 Bt.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in TRANTOR 99 Bt., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TRANTOR 99 Bt., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".